期刊文献+

Synthesis and cytotoxicity of 28-carboxymethoxy lupane triterpenoids.Preference of 28-O-acylation over 28-O-alkylation of betulm by ethyl bromoacetate

Synthesis and cytotoxicity of 28-carboxymethoxy lupane triterpenoids.Preference of 28-O-acylation over 28-O-alkylation of betulm by ethyl bromoacetate
下载PDF
导出
摘要 28-Carboxymethoxy lupane tritepenoids 3 and 4 were synthesized by alkylation of betulin with the THP protected 2- hydroxyethyl iodide followed by oxidation and reduction. Direct reaction of betulin (5) or betulone (10) with ethyl bromoacetate led to 28-O-acylation, instead of 28-O-alkylation. The targeted compounds 3 and 4 were not cytotoxic at the highest concentration tested (75 μmol/L), suggesting that elongation of the chain length at the 28-position in both betulinic acid (1) and betulonic acid (2) was detrimental to the cytotoxicity. The acylation products 28-O-bromoacetates (Sa, 8b and 11) and 28-O-methoxyacetate 13 exhibited cytotoxicity against several cancer cell lines tested. 28-Carboxymethoxy lupane tritepenoids 3 and 4 were synthesized by alkylation of betulin with the THP protected 2- hydroxyethyl iodide followed by oxidation and reduction. Direct reaction of betulin (5) or betulone (10) with ethyl bromoacetate led to 28-O-acylation, instead of 28-O-alkylation. The targeted compounds 3 and 4 were not cytotoxic at the highest concentration tested (75 μmol/L), suggesting that elongation of the chain length at the 28-position in both betulinic acid (1) and betulonic acid (2) was detrimental to the cytotoxicity. The acylation products 28-O-bromoacetates (Sa, 8b and 11) and 28-O-methoxyacetate 13 exhibited cytotoxicity against several cancer cell lines tested.
机构地区 Advanced Life Sciences
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2009年第10期1141-1144,共4页 中国化学快报(英文版)
关键词 Betulinic acid BETULIN Betulonic acid 28-O-Alkylation 28-O-Acylation CYTOTOXICITY Betulinic acid Betulin Betulonic acid 28-O-Alkylation 28-O-Acylation Cytotoxicity
  • 相关文献

参考文献22

  • 1D. Eiznhamer, Z.Q. Xu, IDrugs 7 (2004) 359.
  • 2R.H. Cichewicz, S. Kouzi, Med. Res. Rev. 24 (2004) 90.
  • 3E. Pisha, H. Chai, I.S. Lee, et al. Nat. Med. 1 (1995) 1046.
  • 4V. Zuco, R. Supino, S.C. Righetfi, et al. Cancer Lett. 175 (2002) 17.
  • 5W. Wick, C. Grimmel, B.Wagenknecht et al. J. Pharmacol. Exp. Ther. 293 (1999) 1306;.
  • 6E. Seizer, E. Pimentel, V. Wacheck, et al. J. Invest. Derrnatol. 114 (2000) 935.
  • 7S. Fulda, C. Friesen, M. Los, et al. Cancer Res. 57 (1997) 4956.
  • 8S. Fulda, C. Scaffidi, S.A. Susin, et al. J. Biol. Chem. 273 (1998) 33942;.
  • 9S. Fulda, K.M. Debatin, Med. Pediatr. Oncol. 35 (2000) 616.
  • 10S. Fulda, K.-M, Debatin, Neoplasia 7 (2005) 162.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部